Industry news
-
Business Council Meeting Sees Two New Partnerships
05 November 2013
Russian government officials, led by two deputy ministers, met with U.S. business representatives and lobbyists for a two-day conference in Houston to exchange their views on doing business in Russia.
-
Russia best place for investments – medical company executive
05 November 2013
As the "Open Innovations" Forum in Moscow is in full swing presenting new cutting edge technologies, Steven Oesterle, Senior Vice President of Corporate Strategy and Innovation at Medtronic Inc., in an interview to Voice of Russia outlined what his company has to contribute to the global development of technology.
-
Evaluation of Russian pharmaceutical market
30 October 2013
The company " Coface ", which is an expert in the field of commercial risks and the global leader in credit insurance , has introduced the first quarterly report on the evaluation of the Russian pharmaceutical market . Estimation of capacity of the pharmaceutical market as a whole and its individual elements may vary depending on the source of the information . This is due to the fact that different media outlets can use divergent ways of grouping types of pharmaceutical activity by sector. The ratio of domestic and imported drugs in the Russian market remained stable in 2011 - 1 half of 2013 , and in value terms, imports cover about 75 % of the market , and in-kind - only 40% ( in 2011 the share of slightly shifted in favor of imported goods).
-
NASDAQ OMX and Moscow Exchange Launch Partnership to Promote the Russian Tech and Biotech Community
23 October 2013
NASDAQ OMX (NDAQ) and Moscow Exchange (MOEX) today announced the signing of a co-operation agreement. Within this agreement both exchanges will work jointly in further developing the Russian technology and biotechnology community. The aim of the co-operation is to jointly facilitate access to capital for the fast growing Russian start-up community and to promote listings at both exchanges.
-
VC funding follows tepid pace in Q3 as first-time biotech rounds shrive
21 October 2013
Biotech companies in the U.S. drew a weak $852 million in venture support over the past quarter, a distinct downturn over a burst of new financing rounds in the second quarter. That dollar figure represented a 39% plunge from the second quarter, though the smaller bankroll was divided among 123 deals, with a 10% jump in the number of companies involved.
-
Russia: pharma sales "to grow 11% this year"
21 October 2013
Pharmaceutical sales in Russia are expected to reach $24.29 billion this year from $22.22 billion in 2012, which is up 9.3% in US dollars and 11% in local currency terms, says new research.
-
FierceMedicalDevices' 2013 Fierce 15
21 October 2013
This year's crop endured the struggles many startups face and came out ahead. They've attracted substantial funding from major investors in a tough market, proving the worth of their products. Many are also already in--or close to--market with their signature products, a sign of stability that draws investor commitments much more these days than companies on the earlier side of development.
-
“Rusnano” established the managing company for itself
21 October 2013
The Board of directors of “Rosnano”, OJSC has approved a deal, foreseeing investment of 990K RUB in the charter capital of the established “Managing Company “Rosnano”, LLC. In future it will become private, and the idea of privatization of “Rosnano” recedes into the past. The Managing Company is established in accordance with approved in June, 2012 new strategy of “Rosnano”, the core of which is separation of management functions and assets owning.
-
Consumer Spending is Expected to Cool in Russia’s Pharmaceuticals & Healthcare Sector
14 October 2013
Business Monitor examines key issues affecting the Pharmaceuticals and healthcare industry in Russia and provides short- and long-term forecasts for the sector.
-
Elsevier Contributes Scopus Data to Development of Russian Map of Science
14 October 2013
Russian Ministry of Education has signed an agreement to include Scopus Custom Data in the development of a national research assessment tool Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that the Russian Ministry of Education and Science has signed an agreement to include Scopus Custom Data in a nation-wide research assessment tool: Russia's Map of Science.
